European Archives - Page 138 of 1111 - European Medical Journal

Metabolic Imaging Distinguishes Ovarian Cancer Subtypes

Hyperpolarised 13C magnetic resonance spectroscopy can clinically distinguish between ovarian tumour subtypes.

New Study Uncovers the Role of MYO1F Protein in T Cell Metabolism and Cancer

Researchers have identified the protein MYO1F as a key regulator of T cell metabolism, with implications for immune responses, cancer, and autoimmune diseases…

Twice-Yearly Lenacapavir Shows Promise for HIV Prevention in Diverse Populations

A Phase 3 trial highlights the potential of twice-yearly subcutaneous lenacapavir as an effective PrEP option for diverse populations at risk of HIV infection.

Gluten-Free Diet for Coeliac Disease: Is it Enough?

While a gluten-free diet improves wellbeing, it does not fully reverse coeliac disease impact on gut function or microbiota composition, according to new research.

Acne Measures Fall Short on LGBTQ+-Inclusive Language

A new study reveals that many acne-specific patient-reported outcome measures lack LGBTQ+-inclusive language, potentially undermining care for diverse patient populations.

New Research Links Seasonal Flu to Increased Mortality in Heart Failure

Seasonal flu increases deaths and hospitalisations in heart failure patients, stressing the need for enhanced prevention.

Efficacy of High-Dose Vitamin D for Overactive Bladder Dry

High-dose vitamin D supplementation significantly improves voiding frequency and other symptoms in children with overactive bladder

Prenatal Exposure to Phenols Linked to Increased Asthma Risk in Children

Prenatal exposure to common phenols, including butylparaben, has been linked to an increased risk of asthma in children, particularly among boys, according to a large-scale study from Japan.

Brain Imaging Reveals Key Changes in Opioid Use Disorder Patients: RSNA 2024

Imaging methods reveal brain alterations caused by opioid use.

New Insights into Depression: Skull Bone Marrow, Sinuses, and Inflammation

Imaging reveals how skull regions mediate brain-periphery immune crosstalk in depression, uncovering new therapeutic targets.